Dual Approval For Verzenio Under International Review Scheme

The joint review by Australia and Canada of the metastatic breast cancer drug, Verzenio, helped regulators in both jurisdictions achieve efficiencies.

Handshake
Australian and Canadian regulators highlight the advantages of working together • Source: Shutterstock

More from Approvals

More from Product Reviews